Wells Fargo & Company Lowers Molina Healthcare (NYSE:MOH) Price Target to $375.00

Molina Healthcare (NYSE:MOH) had its price objective lowered by investment analysts at Wells Fargo & Company from $410.00 to $375.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 9.27% from the company’s previous close.

Several other analysts also recently issued reports on the company. StockNews.com downgraded Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Barclays reduced their price objective on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a research report on Thursday. Truist Financial lifted their price objective on Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a research note on Tuesday, February 20th. Finally, Stephens reiterated an “equal weight” rating and issued a $390.00 price objective on shares of Molina Healthcare in a research note on Thursday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $397.20.

Molina Healthcare Trading Up 0.3 %

NYSE:MOH traded up $0.97 on Monday, hitting $343.20. 162,453 shares of the stock were exchanged, compared to its average volume of 401,204. The stock has a market cap of $20.11 billion, a PE ratio of 18.67, a PEG ratio of 0.96 and a beta of 0.47. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The stock has a fifty day moving average of $390.34 and a 200-day moving average of $372.35. Molina Healthcare has a fifty-two week low of $266.35 and a fifty-two week high of $423.92.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.45 billion. During the same quarter last year, the firm earned $5.81 earnings per share. The company’s revenue for the quarter was up 21.9% compared to the same quarter last year. As a group, equities analysts expect that Molina Healthcare will post 23.62 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares in the company, valued at $4,494,567.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,711 shares of company stock worth $6,472,517. Company insiders own 1.11% of the company’s stock.

Institutional Trading of Molina Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of Molina Healthcare during the third quarter worth $30,000. McIlrath & Eck LLC bought a new stake in shares of Molina Healthcare in the fourth quarter worth $34,000. VisionPoint Advisory Group LLC grew its stake in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after purchasing an additional 57 shares during the last quarter. Raleigh Capital Management Inc. grew its stake in shares of Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after purchasing an additional 36 shares during the last quarter. Finally, Principal Securities Inc. bought a new stake in shares of Molina Healthcare in the fourth quarter worth $42,000. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.